两种肌萎缩侧索硬化基因表达谱差异性比较

Abstract
Figure/Table
References
Related Citation (3)

Download: PDF (749 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the difference of gene expressions between C9orf72 mutation ALS and CHMP2B mutation ALS.Methods Datasets (GSE68605 and GSE19332) were acquired from the gene expression omnibus (GEO) database. R software (version 3.5.0), Cytoscape 3.6.1 software and online tool DAVID and STRING were used for data analysis.Results A total of eleven independent samples (eight samples of C9orf72 mutation ALS and three samples of CHMP2B mutation ALS) were analyzed. Thirteen differentially expressed genes (DEGs) were identified in the cervical spinal cord motor neurons of the two distinct ALS variants. It was found that only CALM2, CALM1, CALM3 and RYR2 were classified during GO and KEEG functional enrichment, and that CALM1, CALM2 and CALM3 were outstanding in the Hub protein analysis.Conclusions The expression of CALM genes is up-regulated in the C9orf72 mutation ALS. Calmodulin might be a potential biomarker for ALS diagnosis and effective target for ALS treatment.

Key words： amyotrophic lateral sclerosis C9orf72 CHMP2B CALM calmodulin

Received: 08 October 2018

ZTFLH:

R741

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIN Qipeng
	ZHU Qian
	and MA Liwei

Cite this article:

LIN Qipeng,ZHU Qian,and MA Liwei. Comparison of profiles between c9orf72-mutant amyotrophic lateral sclerosis and CHMP2B amyotrophic lateral sclerosis based on bioinformatics analysis[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(2): 124-127.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I2/124

[1]	Mehta P, Kaye W, Raymond J, et al. Prevalence of amyotrophic lateral sclerosis-United States, 2014[J]. MMWR Morb Mortal Wkly Rep, 2018,67(7): 216-218.
[2]	Mehta P, Horton D K, Kasarskis E J, et al. CDC Grand Rounds: national amyotrophic lateral sclerosis (ALS) registry impact, challenges, and future directions[J]. MMWR Morb Mortal Wkly Rep, 2017,66(50): 1379-1382.
[3]	Kab S, Moisan F, Preux P M, et al. Nationwide incidence of motor neuron disease using the French health insurance information system database[J]. Amyotroph Lat Scl Fr, 2017,18(5-6): 426-433.
[4]	Recabarren L D, Alarcon M.New insights into the gene expression associated to amyotrophic lateral sclerosis[J]. Life Sci,2018,193: 110-123.
[5]	Chia R, Chio A, Traynor B J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications[J]. Lancet Neurol,2018,17(1): 94-102.
[6]	Cooper K J, Bury J J, Heath P R, et al. C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis[J]. PLoS One,2015,10(5): e0127376.
[7]	Cox L E, Ferraiuolo L, Goodall E F, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS)[J].PLoS One, 2010,5(3): e9872.
[8]	Chen C, Grennan K, Badner J, et al. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods[J]. PLoS One, 2011,6(2): e17238.
[9]	Rong L, Huang W, Tian S, et al. COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: integrating bioinformatics and meta-analysis[J]. Pathol Oncol Res, 2018,24(1): 129-134.
[10]	Lin Z, Lin Y. Identification of potential crucial genes associated with steroid-induced necrosis of femoral head based on gene expression profile[J]. Gene,2017,627: 322-326.
[11]	Chin C H, Chen S H, Wu H H, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol, 2014,8(4): S11.
[12]	Villalobo A, Ishida H, Vogel H J, et al. Calmodulin as a protein linker and a regulator of adaptor/scaffold proteins[J]. Biochim Biophys Acta, 2018,1865(3): 507-521.
[13]	Marshall C B, Nishikawa T, Osawa M, et al. Calmodulin and STIM proteins:two major calcium sensors in the cytoplasm and endoplasmic reticulum[J]. Biochem Biophys Res Commun, 2015,460(1): 5-21.
[14]	Engelen-Lee J, Blokhuis A M, Spliet W G, et al. Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis[J]. Amyotroph Lat Scl Fr,2017,18(3-4): 210-220.
[15]	Takemoto-Kimura S, Suzuki K, Horigane S I, et al. Calmodulin kinases: essential regulators in health and disease[J]. J Neurochem,2017,141(6): 808-818.
[16]	Chou S M, Wang H S, Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND[J]. J Neurol Sci,1996,139: 16-26.
[17]	Elliott J L, Snider W D. Parvalbumin is a marker of ALS-resistant motor neurons.[J]Neuroreport,1995,6(3): 449-452.